Open Insider Trading Activity for Epirus Biopharmaceuticals, Inc. Chief Business Officer Vincent Aurentz
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. EPRS | 2015-12-21 | 2015-12-17 | Epirus Biopharmaceuticals, Inc. | Vincent Aurentz | Chief Business Officer | Buy | 1 | 2,200 | $3.43 | $7,546.00 | 100.00% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. EPRS | 2015-12-11 | 2015-12-09 | Epirus Biopharmaceuticals, Inc. | Vincent Aurentz | Chief Business Officer | Buy | 1 | 2,800 | $3.85 | $10,780.00 | 100.00% | View Filing |